Slingshot Biosciences is a Biotech company. It has raised $49M in total funding. Latest round: Series A.
Slingshot Biosciences is a Biotech company. Slingshot Biosciences has raised $49M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in February 2023. The round record for Slingshot Biosciences runs through 2023; nothing later has been disclosed. Investors on record include ARCH Venture Partners, Northpond Ventures, Anterra Capital. 3 distinct backers are named across the disclosed rounds.
Every Slingshot Biosciences figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare Biotech companies at a similar stage.
Company funding database · Investor directory · Founder database · Mega-rounds 2026